Paper Details

  1. Home
  2. Paper Details

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis.

Author: Angeles-HanSheila T, Barbar-SmileyFatima, BeckerMara L, CooperAshley M, CronRandy Q, CuelloCarlos A, EdelheitBarbara, FeldmanBrian M, FergusonPolly J, FlanaganElaine, GewanterHarry, Gillispie-TaylorMiriah, GuzmanJaime, HaysKimberly, HortonDaniel B, KimuraYukiko, Klein-GitelmanMarisa, LeeTzielan, LovellDaniel J, MannionMelissa L, MurphyKatherine, NigrovicPeter A, OmbrelloMichael J, OnelKaren B, PetersonRosemary, RabinovichC Egla, RestonJames T, SaadNadine, ShenoiSusan, SullivanNancy, SzymanskiAnn Marie, TesherMelissa, TrachtmanRebecca, TurgunbaevMarat, TurnerAmy S, TwiltMarinka, VeigaKeila

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, N.I.H., IntramuralFunding provided by the NIH for research projects within the NIH.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This study provides updated guidelines for the pharmacologic management of juvenile idiopathic arthritis (JIA), focusing on treatment of oligoarthritis, temporomandibular joint (TMJ) arthritis, and systemic JIA with and without macrophage activation syndrome.
Paper Details　
Original Abstract of the Article :
To provide updated guidelines for pharmacologic management of juvenile idiopathic arthritis (JIA), focusing on treatment of oligoarthritis, temporomandibular joint (TMJ) arthritis, and systemic JIA with and without macrophage activation syndrome. Recommendations regarding tapering and discontinuing ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/35233986

データ提供：米国国立医学図書館（NLM）

Treating Juvenile Idiopathic Arthritis: A Guide for Clinicians

Juvenile idiopathic arthritis (JIA), a chronic inflammatory disease affecting children, can be a challenging condition to manage. This updated guideline provides a comprehensive overview of pharmacologic management for JIA, focusing specifically on oligoarthritis, temporomandibular joint (TMJ) arthritis, and systemic JIA, including those with macrophage activation syndrome.

The guideline offers evidence-based recommendations for tapering and discontinuing treatment in inactive systemic JIA, providing clinicians with a structured approach to managing this complex disease. This thorough guide serves as a valuable resource for healthcare professionals seeking to optimize care and improve outcomes for children with JIA.

Juvenile Idiopathic Arthritis: A Long and Winding Road

Juvenile idiopathic arthritis (JIA) is a complex condition, like navigating a long and winding desert trail. This guideline offers a helpful roadmap for clinicians, providing guidance on the best strategies for managing this challenging disease. It emphasizes the importance of a personalized approach, tailoring treatment plans to individual patient needs and circumstances, ensuring optimal outcomes and a smoother journey for children with JIA.

Navigating the Desert of JIA: A Guide for Healthcare Professionals

This updated guideline serves as a valuable compass for healthcare professionals navigating the complexities of juvenile idiopathic arthritis (JIA). It provides evidence-based recommendations for treatment, offering a clear path to optimal care and improved outcomes for children living with this condition.

Dr.Camel's Conclusion

Juvenile idiopathic arthritis (JIA) is a challenging condition, like a long trek across a vast desert. This guideline provides clinicians with a valuable map, guiding them through the complexities of treatment and ensuring the best possible outcomes for children with JIA. It's a testament to the ongoing pursuit of better treatments and improved quality of life for those who face the challenges of this chronic disease.

Date :
  1. Date Completed 2022-05-04
  2. Date Revised 2023-04-25
Further Info :

Pubmed ID

35233986

DOI: Digital Object Identifier

NIHMS1892175

Related Literature

Article Analysis
・Effective treatment of arthritis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.